Freedom Day Solutions’s Quest Diagnostics DGX Stock Holding History

Freedom Day Solutions’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17,134	Closed	-$1.38M	–	89
2020 Q1	$1.38M	Sell	17,134 -1,457	-8%	-$151K	1.17%	42
2019 Q4	$1.99M	Sell	18,591 -10	-0.1%	-$1.04K	1.33%	34
2019 Q3	$1.99M	Sell	18,601 -124	-0.7%	-$12.7K	1.45%	31
2019 Q2	$1.91M	Buy	18,725 +590	+3%	+$56.7K	1.45%	31
2019 Q1	$1.63M	Sell	18,135 -761	-4%	-$65.9K	1.34%	35
2018 Q4	$1.57M	Sell	18,896 -736	-4%	-$69K	1.65%	26
2018 Q3	$2.12M	Sell	19,632 -697	-3%	-$76.4K	1.67%	21
2018 Q2	$2.23M	Sell	20,329 -17	-0.1%	-$1.77K	1.82%	15
2018 Q1	$2.04M	Sell	20,346 -372	-2%	-$38.1K	1.78%	24
2017 Q4	$2.04M	Buy	+20,718	New	+$1.96M	1.73%	27

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Freedom Day Solutions's DGX Position: Q2 2020 in Review

Freedom Day Solutions sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 17,134 shares — an estimated $1.38M sold.

Freedom Day Solutions first reported a position in DGX in Q4 2017 and held it in 10 quarters. The position peaked at $2.23M in Q2 2018. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

Freedom Day Solutions reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
Freedom Day Solutions sold 17,134 Quest Diagnostics shares in Q2 2020, an estimated $1.38M.
Freedom Day Solutions first reported a position in Quest Diagnostics in Q4 2017 and held it in 10 quarters.
Freedom Day Solutions's Quest Diagnostics position peaked at $2.23M in Q2 2018.
748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Freedom Day Solutions's 13F filing for Q2 2020, filed 27 Jul 2020.